advs {pharmaverseadam} | R Documentation |
Vital Signs Analysis
Description
An example of ADVS ADaM dataset
Usage
advs
Format
A data frame with 101 columns:
- STUDYID
Study Identifier
- DOMAIN
Domain Abbreviation
- USUBJID
Unique Subject Identifier
- VSSEQ
Sequence Number
- VSTESTCD
Vital Signs Test Short Name
- VSTEST
Vital Signs Test Name
- VSPOS
Vital Signs Position of Subject
- VSORRES
Result or Finding in Original Units
- VSORRESU
Original Units
- VSSTRESC
Character Result/Finding in Std Format
- VSSTRESN
Numeric Result/Finding in Standard Units
- VSSTRESU
Standard Units
- VSSTAT
Completion Status
- VSLOC
Location of Vital Signs Measurement
- VSBLFL
Baseline Flag
- VISITNUM
Visit Number
- VISIT
Visit Name
- VISITDY
Planned Study Day of Visit
- VSDTC
Date/Time of Measurements
- VSDY
Study Day of Vital Signs
- VSTPT
Planned Time Point Name
- VSTPTNUM
Planned Time Point Number
- VSELTM
Planned Elapsed Time from Time Point Ref
- VSTPTREF
Time Point Reference
- TRTSDT
Date of First Exposure to Treatment
- TRTEDT
Date of Last Exposure to Treatment
- TRT01A
Actual Treatment for Period 01
- TRT01P
Planned Treatment for Period 01
- ADT
Analysis Date
- ADY
Analysis Relative Day
- PARAMCD
Parameter Code
- AVAL
Analysis Value
- ATPTN
Analysis Timepoint (N)
- ATPT
Analysis Timepoint
- AVISIT
Analysis Visit
- AVISITN
Analysis Visit (N)
- DTYPE
Derivation Type
- ONTRTFL
On Treatment Record Flag
- ANRLO
Analysis Normal Range Lower Limit
- ANRHI
Analysis Normal Range Upper Limit
- A1LO
Analysis Range 1 Lower Limit
- A1HI
Analysis Range 1 Upper Limit
- ANRIND
Analysis Reference Range Indicator
- BASETYPE
Baseline Type
- ABLFL
Baseline Record Flag
- BASE
Baseline Value
- BNRIND
Baseline Reference Range Indicator
- CHG
Change from Baseline
- PCHG
Percent Change from Baseline
- ANL01FL
Analysis Flag 01
- TRTP
Planned Treatment
- TRTA
Actual Treatment
- ASEQ
Analysis Sequence Number
- AVALCA1N
Analysis Value Category 1 (N)
- AVALCAT1
Analysis Value Category 1
- PARAM
Parameter
- PARAMN
Parameter (N)
- SUBJID
Subject Identifier for the Study
- RFSTDTC
Subject Reference Start Date/Time
- RFENDTC
Subject Reference End Date/Time
- RFXSTDTC
Date/Time of First Study Treatment
- RFXENDTC
Date/Time of Last Study Treatment
- RFICDTC
Date/Time of Informed Consent
- RFPENDTC
Date/Time of End of Participation
- DTHDTC
Date/Time of Death
- DTHFL
Subject Death Flag
- SITEID
Study Site Identifier
- AGE
Age
- AGEU
Age Units
- SEX
Sex
- RACE
Race
- ETHNIC
Ethnicity
- ARMCD
Planned Arm Code
- ARM
Description of Planned Arm
- ACTARMCD
Actual Arm Code
- ACTARM
Description of Actual Arm
- COUNTRY
Country
- DMDTC
Date/Time of Collection
- DMDY
Study Day of Collection
- TRTSDTM
Datetime of First Exposure to Treatment
- TRTSTMF
Time of First Exposure Imput. Flag
- TRTEDTM
Datetime of Last Exposure to Treatment
- TRTETMF
Time of Last Exposure Imput. Flag
- TRTDURD
Total Treatment Duration (Days)
- SCRFDT
Screen Failure Date
- EOSDT
End of Study Date
- EOSSTT
End of Study Status
- FRVDT
Final Retrievel Visit Date
- RANDDT
Date of Randomization
- DTHDT
Date of Death
- DTHADY
Relative Day of Death
- LDDTHELD
Elapsed Days from Last Dose to Death
- LSTALVDT
Date Last Known Alive
- AGEGR1
Pooled Age Group 1
- SAFFL
Safety Population Flag
- RACEGR1
Pooled Race Group 1
- REGION1
Geographic Region 1
- LDDTHGR1
Last Dose to Death - Days Elapsed Grp 1
- DTH30FL
Death Within 30 Days of Last Trt Flag
- DTHA30FL
Death After 30 Days from Last Trt Flag
- DTHB30FL
Death Within 30 Days of First Trt Flag
Source
Generated from admiral package (template ad_advs.R).
References
None
Examples
data("advs")